Conversely, in another syngeneic mouse model of bone metastasis‐prone breast cancer, PARP2 deficiency increased bone metastasis by altering the balance between regulatory T and T helper 1 cells, thereby converting the bone microenvironment into an immunosuppressive state [47] (Figure 4B). The gene discussed is PARP2; the disease is breast carcinoma.